ANI Pharmaceuticals, Inc. (ANIP)
82.13
+0.10
(+0.12%)
USD |
NASDAQ |
Dec 11, 16:00
82.12
-0.01
(-0.01%)
After-Hours: 20:00
ANI Pharmaceuticals Research and Development Expense (Quarterly): 12.30M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| CorMedix, Inc. | 5.098M |
| Arcutis Biotherapeutics, Inc. | 19.60M |
| Intellia Therapeutics, Inc. | 92.33M |
| Beam Therapeutics, Inc. | 109.77M |
| Halozyme Therapeutics, Inc. | 17.25M |